Two-Colour Fluorescence Marker for Neurodegenerative Diseases
Worldwide it is estimated that there are 29 million cases of Alzheimer Disease (AD) and about 4 million of Parkinson's Disease (PD). The world market for AD and PD is estimated to be 14 billion dollars corresponding to an annual growth rate of 20%, making it an very attractive field for R&D to generate novel therapeuticals. Recently, the accumulation of dysfunctional mitochondria has been linked to neurodegenerative diseases, in particular to AD and PD. Scientists at the University of Göttingen have developed a powerful fluorescent marker for Live Cell Imaging to study mitochondrial dysfunctions and for testing novel pharmaceutical products
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Webb captures top of iconic horsehead nebula in unprecedented detail
NASA’s James Webb Space Telescope has captured the sharpest infrared images to date of a zoomed-in portion of one of the most distinctive objects in our skies, the Horsehead Nebula….
Cost-effective, high-capacity, and cyclable lithium-ion battery cathodes
Charge-recharge cycling of lithium-superrich iron oxide, a cost-effective and high-capacity cathode for new-generation lithium-ion batteries, can be greatly improved by doping with readily available mineral elements. The energy capacity and…
Novel genetic plant regeneration approach
…without the application of phytohormones. Researchers develop a novel plant regeneration approach by modulating the expression of genes that control plant cell differentiation. For ages now, plants have been the…